The Nuclear Energy Corporation of South Africa, Necsa, is proposing to reappoint its suspended and subsequently fired former CEO Phumzile Tshelane as a highly paid consultant to the state-owned enterprise.
This emerged following a Necsa board meeting on Thursday, 28 May, where the board authorised its chairman, David Nicholls, to approach the minister of minerals and energy, Gwede Mantashe, to seek the reappointment of Tshelane as a consultant to Necsa on a limited-term contract.
When asked for comment, Mantashe indicated that he is not a member of the Necsa board and is unaware of the details. However, he confirmed that the proposed reappointment was raised with him on Friday 29 May by the Necsa chairman, and tOp_Ehat a meeting to address the matter has been scheduled for this week.
It is understood that, at this stage, the consulting contract envisaged by the Necsa board for former CEO Tshelane would be for a term of about six months. His first task would be to make progress on the establishment of a state-owned pharmaceutical company, Ketlaphela Pharmaceuticals, to manufacture anti-retroviral (ARV) drugs in South Africa.
Ketlaphela Pharmaceuticals is a subsidiary of Pelchem, a company in deep financial distress. Pelchem,...